- Home
- TRI vs EW Comparison
TRI vs EW Comparison
Compare TRI & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRI | EW |
|---|---|---|
| Founded | 1851 | 1958 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.4B | 48.9B |
| IPO Year | 2002 | 1999 |
Fundamental Metrics
Financial Performance| Metric | TRI | EW |
|---|---|---|
| Price | $97.64 | $84.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 21 |
| Target Price | ★ $154.58 | $96.37 |
| AVG Volume (30 Days) | 1.5M | ★ 2.6M |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | ★ $6,067,600,000.00 |
| Revenue This Year | $8.90 | $13.39 |
| Revenue Next Year | $7.89 | $9.81 |
| P/E Ratio | ★ $25.72 | $80.54 |
| Revenue Growth | N/A | ★ 11.55 |
| 52 Week Low | $76.28 | $72.30 |
| 52 Week High | $173.39 | $96.29 |
Technical Indicators
Market Signals| Indicator | TRI | EW |
|---|---|---|
| Relative Strength Index (RSI) | 41.71 | 35.76 |
| Support Level | $79.70 | $81.19 |
| Resistance Level | $100.66 | $86.78 |
| Average True Range (ATR) | 3.60 | 1.88 |
| MACD | -1.52 | -0.62 |
| Stochastic Oscillator | 0.36 | 17.92 |
Price Performance
Historical ComparisonAbout TRI Thomson Reuters Corp
Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.